Treatments for Rare malignant breast tumor
FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.
ℹ
Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.
Report missing dataFDA-approved treatments (6)
- Abraxanepaclitaxel protein-bound particlesAbraxis BioScience, LLC
- Tamoxifen CitrateTAMOXIFEN CITRATEA-S Medication Solutions
- Halaveneribulin mesylateEisai Inc.
- TaxolPaclitaxelBristol-Myers Squibb Pharmaceutical Research Institute
- FarestonToremifeneOrion Corporation
- EllenceEpirubicinPharmacia & Upjohn CompanyApproved Sep 1999
Patient support programs (8)
Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.
Herceptin
Genentech
Breast Cancer
Verified 18d ago
copay card
Copay CardPatient Assistance
Accepting applications
Eribulin Mesylate
Eisai
Breast Cancer
Verified 17d ago
copay card
Copay CardPatient Assistance
Accepting applications
Tamoxifen Citrate
AstraZeneca
Breast Cancer
Verified 17d ago
copay card
Copay CardPatient Assistance
Accepting applications
Herceptin Hylecta
Genentech
Breast Cancer
Verified 18d ago
copay card
Copay CardPatient Assistance
Accepting applications
Paclitaxel protein-bound particles
Bristol Myers Squibb
Breast Cancer
Verified 17d ago
copay card
Copay CardPatient Assistance
Accepting applications
Fareston
Orion
Breast Cancer
Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications
Halaven
Eisai
Breast Cancer
Verified 17d ago
copay card
Copay CardPatient Assistance
Accepting applications
Ellence
Pfizer
Breast Cancer
Verified 17d ago
copay card
Copay CardPatient Assistance
Accepting applications